Showing results (41-50 of 69) with videos related to
Sort By:
Pageof 7
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Modulation of multidrug resistance by BIBW22BS in blasts of de novo or relapsed or persistent acute myeloid leukemia ex vivoJ Schröder, M Esteban, M R Müller, et al.Deutsche Medizinische Wochenschrift (1946)|April 4, 1980
[Combined chemo- and radiotherapy in inoperable small-cell anaplastic bronchial carcinoma (author's transl)]S Seeber, R B Schilcher, P Swosdyk, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 12, 2005
Risk factors for venous thromboembolic events in cancer patientsK Kröger, D Weiland, C Ose, et al.Oncology|January 1, 1991
Ifosfamide, methotrexate and 5-fluorouracil for pretreated advanced breast cancerR Becher, H Höfeler, O Kloke, et al.European Journal of Medical Research|February 21, 1997
Phase I and pharmacokinetic study of the P-glycoprotein modulator dexniguldipine-HCLV Nuessler, M E Scheulen, R Oberneder, et al.Blut|June 18, 1979
[Effect of long-term cytostatic therapy on the hematopoietic stem cells]M R Nowrousian, U W Schaefer, S Ohl, et al.Bone Marrow Transplantation|October 1, 1993
Constant intravenous pentoxifylline infusions in allogeneic marrow transplant recipients: results of a dose escalation studyD W Beelen, H G Sayer, M Franke, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancerD Strumberg, S Brügge, M W Korn, et al.Neurology|March 23, 2005
Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worseningC C P Verstappen, S Koeppen, J J Heimans, et al.British Journal of Cancer|May 29, 2008
Oxaliplatin-DNA adduct formation in white blood cells of cancer patientsA C Pieck, A Drescher, K G Wiesmann, et al.Pageof 7